Human retinal molecular weight exclusion limit and estimate of species variation

被引:120
作者
Jackson, TL [1 ]
Antcliff, R [1 ]
Hillenkamp, J [1 ]
Marshall, J [1 ]
机构
[1] St Thomas Hosp, Rayne Inst, Dept Ophthalmol, London SE1 7EH, England
关键词
D O I
10.1167/iovs.02-1027
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. To determine the maximum size of molecule capable of freely diffusing across human retina, referred to as the retinal exclusion limit (REL), and the location of any sites of high resistance to diffusion. To assess the degree of interspecies variation in the REL of three animals commonly used to model human disease. METHODS. Trephines of human neuroretina were mounted in a modified Ussing chamber. FITC-dextrans of various molecular weights (MWT) were dissolved in phosphate-buffered saline, and the rate of transretinal diffusion was determined over 24 hours with a spectrophotometer. The theoretical REL was calculated by extrapolating the linear relationship between the rate of diffusion and log(MWT). In separate experiments to determine the sites of barrier to diffusion, FITC-dextrans with a MWT greater than the calculated REL were applied to either the inner or outer retinal surface, processed as frozen sections, and viewed with a fluorescence microscope. Experiments to determine the REL were repeated in bovine, porcine, and rabbit retina. RESULTS. The REL in human tissue was 76.5 +/- 1.5 kDa (6.11 +/- 0.04 nm). The inner and outer plexiform. layers formed the sites of highest resistance to diffusion. The REL in pigs, cattle, and rabbits were 60 +/- 11.5, 78.5 +/- 20.5, and 86 +/- 30 kDa, respectively (5.68 +/- 0.45, 6.18 +/- 0.61, and 6.38 +/- 0.88 nm). CONCLUSIONS. In humans, the inner and outer plexiform layers are sites of high resistance to the diffusion of large molecules, resulting in an REL of 76.5 kDa. There was only moderate interspecies variation in the REL of the animals studied, suggesting that they provide adequate models for the study of human transretinal macromolecular diffusion.
引用
收藏
页码:2141 / 2146
页数:6
相关论文
共 24 条
[1]  
Alm A., 1992, Adler's physiology of the eye, P198
[2]  
Ambati J, 2000, INVEST OPHTH VIS SCI, V41, P1186
[3]  
Antcliff R J, 1999, Semin Ophthalmol, V14, P223, DOI 10.3109/08820539909069541
[4]  
Antcliff RJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P539
[5]   The use of intravitreal tissue plasminogen activator in the treatment of experimental subretinal hemorrhage in the pig model [J].
Boone, DE ;
Boldt, HC ;
Ross, RD ;
Folk, JC ;
Kimura, AE .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 1996, 16 (06) :518-524
[6]  
BUNTMILAM AH, 1985, INVEST OPHTH VIS SCI, V26, P1377
[7]  
BURSTEIN NL, 1985, J OCUL PHARMACOL, V2, P153
[8]   EFFECT OF INTRAVITREAL TISSUE-PLASMINOGEN ACTIVATOR ON EXPERIMENTAL SUBRETINAL HEMORRHAGE [J].
COLL, GE ;
SPARROW, JR ;
MARINOVIC, A ;
CHANG, S .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 1995, 15 (04) :319-326
[9]  
CURRY FE, 1984, HDB PHYSL 4 1, P251
[10]   Surgical removal of submacular hemorrhage using tissue plasminogen activator and perfluorocarbon liquid [J].
Kamei, M ;
Tano, Y ;
Maeno, T ;
Ikuno, Y ;
Mitsuda, H ;
Yuasa, T .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1996, 121 (03) :267-275